Literature DB >> 11476625

The role of T cell help for anti-viral CTL responses.

D Wodarz1, V A Jansen.   

Abstract

Cytotoxic T lymphocyte (CTL or CD8) responses are a major branch of the immune system involved in controlling viral infections. Murine models have shown that the development of effective and sustained CD8 cell responses requires CD4 T cell help. However, the precise mechanism in which CD4 cells provide help for CD8 cell responses is still controversial. In the literature, mainly two mechanisms are discussed. According to the "classical" pathway, CD4 cells secrete cytokines, such as IL-2, which promote the responsiveness of the CD8 cells. According to the "CD4-APC-CD8" pathway, CD4 cells specifically activate antigen presenting cells (APCs), and APCs specifically interact with CD8 cells, thereby delivering help. Here, we derive kinetic models in order to describe and compare both pathways of help. We find that the two pathways might have different roles in different situations. The classical pathway is more efficient at inducing CD8 cell expansion at high virus loads, while the CD4-APC-CD8 pathway is more efficient at inducing CD8 cell proliferation at low virus loads. From this, it follows that the classical pathway might be needed in order to kick-start a CD8 cell response in the acute phase of the infection, while the CD4-APC-CD8 pathway is needed in order to ensure virus clearance when virus load is reduced by the immune system. These findings have implications for the interpretation of experimental data from virus infection in helper-deficient hosts. In particular, the models offer further suggestions for the development of treatment regimes aimed at achieving immunological control of HIV infection which has been shown to crucially depend on the availability of helper cell responses. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11476625     DOI: 10.1006/jtbi.2001.2358

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  18 in total

1.  Infection dynamics in HIV-specific CD4 T cells: does a CD4 T cell boost benefit the host or the virus?

Authors:  Dominik Wodarz; Dean H Hamer
Journal:  Math Biosci       Date:  2007-02-08       Impact factor: 2.144

2.  A parameter sensitivity methodology in the context of HIV delay equation models.

Authors:  H T Banks; D M Bortz
Journal:  J Math Biol       Date:  2004-12-20       Impact factor: 2.259

3.  Conditions for pathogen elimination by immune systems.

Authors:  José Guilherme Chaui-Berlinck; José Alexandre Marzagão Barbuto; Luiz Henrique Alves Monteiro
Journal:  Theory Biosci       Date:  2004-09       Impact factor: 1.919

4.  Role of avidity and breadth of the CD4 T cell response in progression to AIDS.

Authors:  Hester Korthals Altes; Rob de Boer; Maarten Boerlijst
Journal:  Proc Biol Sci       Date:  2006-07-07       Impact factor: 5.349

5.  Infection of HIV-specific CD4 T helper cells and the clonal composition of the response.

Authors:  Sarah M Roy; Dominik Wodarz
Journal:  J Theor Biol       Date:  2012-03-30       Impact factor: 2.691

6.  A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag/pol DNA and recombinant vaccinia virus strain DIs elicits effective anti-SIV immunity.

Authors:  Kenji Someya; Ke-Qin Xin; Kazuhiro Matsuo; Kenji Okuda; Naoki Yamamoto; Mitsuo Honda
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

7.  Interleukin-12 is necessary for the priming of CD4+ T cells required during the elicitation of HIV-1 gp120-specific cytotoxic T-lymphocyte function.

Authors:  Shalini Gupta; Ramanamurthy Boppana; Gyan C Mishra; Bhaskar Saha; Debashis Mitra
Journal:  Immunology       Date:  2008-02-20       Impact factor: 7.397

8.  CD4+ T cells are required for the priming of CD8+ T cells following infection with herpes simplex virus type 1.

Authors:  Naveen K Rajasagi; Sadik H Kassim; Christina M Kollias; Xiangyi Zhao; Robert Chervenak; Stephen R Jennings
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

9.  Persistence of restricted CD4 T cell expansions in SIV-infected macaques resistant to SHIV89.6P superinfection.

Authors:  M-D Salha; R Cheynier; R Halwani; H McGrath; T Y Langaee; B Yassine Diab; J Fournier; M Parenteau; J Edgar; D Ko; A Sherring; D Bogdanovic; R-P Sekaly; E W Rud
Journal:  Virology       Date:  2008-08-01       Impact factor: 3.616

10.  Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults.

Authors:  P Durando; D Fenoglio; A Boschini; F Ansaldi; G Icardi; L Sticchi; A Renzoni; P Fabbri; A Ferrera; A Parodi; B Bruzzone; G Gabutti; A Podda; G Del Giudice; E Fragapane; F Indiveri; P Crovari; R Gasparini
Journal:  Clin Vaccine Immunol       Date:  2007-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.